<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00671151</url>
  </required_header>
  <id_info>
    <org_study_id>FIS042146</org_study_id>
    <nct_id>NCT00671151</nct_id>
  </id_info>
  <brief_title>Effects of Low-Dose Theophylline During Chronic Obstructive Pulmonary Disease (COPD) Exacerbations</brief_title>
  <official_title>Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari Son Dureta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondo de Investigación Sanitaria (FIS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sociedad Española de Neumología y Cirugía Torácica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitari Son Dureta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Molecular mechanisms of COPD exacerbations and the modulating effect of low dose theophylline
      on that inflammation are elucidated in this project. NF-kappa B-dependent pathway and
      acetylation status of nuclear histones are to be studied.Design: controlled, prospective and
      randomized study with or without theophylline, a potent HDAC activator.Objectives: 1) To
      determine NF-kB activation, histone deacetylase (HDAC) and histone acetyl-transferase (HAT)
      activity in sputum macrophages and blood monocytes during an episode of exacerbation and 3
      months later, once stability is achieved. To correlate these measurements with inflammatory
      and oxidative stress markers and with pulmonary function and clinical variables. 2) To assess
      the effect of theophylline on previous molecular, functional and clinical data. Method: 25
      patients with COPD will be recruited during an episode of exacerbation requiring
      hospitalization. NF-kB activation, HDAC and HAT activity, markers of inflammation and
      oxidative stress will be determined with specific assays. These determinations will be
      repeated once the patient is stable and compared with smokers and non smoker controls with
      normal lung function
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HDAC activity in alveolar macrophages</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lung function</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory cytokine release in sputum and serum</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-dose theophylline on top of standard therapy for COPD exacerbation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard therapy for COPD exacerbation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Theophylline</intervention_name>
    <description>Theophylline 100 mg bid for 3 months</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe COPD according to GOLD guidelines

          -  Age between 40 and 75

          -  Admission to hospital due to COPD exacerbation

        Exclusion Criteria:

          -  History of asthma

          -  Pulmonary embolism

          -  Pneumonia

          -  Other chronic inflammatory disease

          -  Patient on theophylline at the time of admission

          -  Patient on oral steroids at the time of admission
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Borja G Cosio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Son Dureta</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Son Dureta</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <zip>07014</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med. 2004 Sep 6;200(5):689-95. Epub 2004 Aug 30.</citation>
    <PMID>15337792</PMID>
  </reference>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2008</study_first_submitted>
  <study_first_submitted_qc>May 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 5, 2008</study_first_posted>
  <last_update_submitted>May 2, 2008</last_update_submitted>
  <last_update_submitted_qc>May 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2008</last_update_posted>
  <responsible_party>
    <name_title>Borja G Cosio MD</name_title>
    <organization>Specialist in Respiratory Medicine</organization>
  </responsible_party>
  <keyword>COPD exacerbation</keyword>
  <keyword>histone</keyword>
  <keyword>steroid resistance</keyword>
  <keyword>inflammation</keyword>
  <keyword>theophylline</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Theophylline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

